ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Constructing a Novel Prognostic Signature Based on TGF-β Signaling for Personalized Treatment in Pancreatic Adenocarcinoma

Ji, Tengfei; Wu, Hongsheng; Ma, Keqiang*南方医科大学
Journal of Oncology2022-9-16DOI: 10.1155/2022/4419119
1被引4阅读
引用收藏
分享

摘要

Background. Pancreatic adenocarcinoma (PAAD) shows significantly high mortality. Transforming growth factor-beta (TGF-beta) signaling plays an important role in tumorigenesis and development. A prognostic model was conducted using transforming growth factor-beta (TGF-beta) signaling for predicting PAAD prognosis and guiding personalized therapies. Methods. Datasets were grouped into test and training sets. Univariate Cox regression analysis and least absolute shrinkage and selection operator (LASSO) were applied and introduced for identifying prognostic genes associated with TGF-beta. Risk score of each sample was calculated by the prognostic model. The difference in survival, clinical information, mutations, pathways, and chemotherapy and immunotherapy sensitivities between high-risk and low-risk groups was analyzed. Results. Based on TGF-beta signaling, this work built a 7-gene prognostic model showing robustness in sample classification into low-risk and high-risk groups with differential prognoses. Oncogenic pathways like glycolysis, Notch signaling, and hypoxia were noticeably enriched in the group with high risk. Interferon and STAT1 were positively associated with risk score. Importantly, the low-risk group may develop a more favorable response to both chemotherapy and immunotherapy. The current work highlighted the significant function of TGF-beta signaling in PAAD development and described the potential cross-links with other oncogenic pathways. Conclusion. Notably, the prognostic signature can act as a predictor of prognosis, but as a biomarker for optimizing personalized therapies in clinical practice.

学科与关键词

关键词
CANCER-IMMUNOTHERAPYCDK9
相关
加载中…
  • Identification of a Four Cancer Stem Cell-Related Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Adenocarcinoma
    Li, Shuanghua*; Chen, Rui*; Luo, Wang; Lin, Jinyu; Chen, Yunlong; Wang, Zhuangxiong; Lin, Wenjun; Li, Baihong; Wang, Junfeng; Yang, JianCOMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2022, 25(12): 2070-2081.被引 1
  • An Inflammatory Response Related Gene Signature Associated with Survival Outcome and Gemcitabine Response in Patients with Pancreatic Ductal Adenocarcinoma
    Xiao, Zhijun; Li, Jinyin; Yu, Qian; Zhou, Ting; Duan, Jingjing; Yang, Zhen; Liu, Cuicui*; Xu, Feng*Frontiers in Pharmacology, 2021, 12: 778294.被引 12
  • Novel necroptosis-related gene signature for predicting the prognosis of pancreatic adenocarcinoma
    Wu, Zixuan; Huang, Xuyan; Cai, Minjie; Huang, Peidong*; Guan, ZunhuiAging-US, 2022, 14(2): 869-891.被引 38
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Oncology
发表日期
2022-09-16
卷期
第 2022 卷
页码
4419119
DOI
10.1155/2022/4419119
期刊等级
4区
成果收录
SCIE

作者

  • J

    Ji, Tengfei (第一作者)

    southern med univ

  • W

    Wu, Hongsheng

    southern med univ

查看全部 3 位作者收起作者
  • M

    Ma, Keqiang (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417